CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)
$3.09 -0.02 (-0.6431%)
Analysed CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) News Sources
Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting
17-03-2026
yahoo.com
Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales
10-03-2026
yahoo.com
Cumberland Pharmaceuticals Inc (CPIX) Q4 2025 Earnings Call Highlights: Revenue Surge and ...
04-03-2026
yahoo.com
Cumberland Pharmaceuticals Q4 Earnings Call Highlights
03-03-2026
marketbeat.com
Cumberland: Q4 Earnings Snapshot
03-03-2026
yahoo.com
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH
03-03-2026
yahoo.com
Joint U.S. Commercialization of RedHill's Talicia® Commences
25-02-2026
yahoo.com
CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA®
25-02-2026
yahoo.com
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE
24-02-2026
yahoo.com
Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program
04-02-2026
yahoo.com
What is the current price of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The current price of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is $3.09.
CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) since the previous trading day is $-0.02.
CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) since the previous trading day is -0.6431%.
What is the most recent average sentiment score for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The most recent average sentiment score for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The most recent sentiment for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is .
SEC-8K** Filing Available For CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.